Skip to main content
    M

    Marker Therapeutics Inc (MRKR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.83
    -0.04 (-4.76%)

    Market Cap: $14.51M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Marker Therapeutics Inc (MRKR) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Marker Therapeutics (MRKR) is expected to report earnings on Mar 16, 2027. In the quarter ended Jun 30, 2026, Marker Therapeutics reported EPS of -$0.09, above the -$0.25 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(19/32)
    Avg Surprise
    -8.00%
    Streak
    4 Q

    Upcoming Estimates

    Reports Mar 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.22
    Range-$0.31 - -$0.13
    5 analysts
    Revenue Consensus
    $729.64K
    RangeN/A
    5 analysts

    Next Report

    MRKR has an expected report date of Mar 16, 2027.

    Earnings History

    Of the 32 quarters below that had an estimate, MRKR beat 19, missed 12 and matched 1. The widest gap in the table came in the quarter ended Dec 31, 2018, when EPS landed 402.46% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$0.09-$0.25N/A+64.00%BeatN/A21 up, 0 downAug 14, 2026N/A
    Mar 31, 2026-$0.16-$0.19-$0.19 - -$0.19+15.79%BeatN/A10 up, 0 downMay 15, 2026N/A
    Dec 31, 2025-$0.04-$0.19-$0.20 - -$0.18+78.95%BeatN/A21 up, 0 downMar 18, 2026$1.10M
    Sep 30, 2025-$0.12-$0.21-$0.21 - -$0.21+42.86%BeatN/A10 up, 0 downNov 13, 2025N/A
    Jun 30, 2025-$0.29-$0.27-$0.27 - -$0.27-7.41%MissN/A10 up, 0 downAug 14, 2025N/A
    Mar 31, 2025-$0.40-$0.66N/A+39.39%BeatN/AN/A0 up, 0 downMay 21, 2025N/A
    Dec 31, 2024-$0.42-$0.22-$0.28 - -$0.16-90.91%MissN/A20 up, 1 downMar 31, 2025$2.25M
    Sep 30, 2024-$0.26-$0.39-$0.39 - -$0.39+33.33%BeatN/A11 up, 0 downNov 14, 2024$1.93M
    Jun 30, 2024-$0.25-$0.43-$0.43 - -$0.43+41.86%Beat-187.4%10 up, 0 downAug 14, 2024$1.17M
    Mar 31, 2024-$0.27-$0.25N/A-8.00%MissN/AN/AN/AMay 15, 2024$1.24M
    Dec 31, 2023-$0.48-$1.00N/A+52.00%BeatN/AN/AN/AMar 26, 2024$1.06M
    Sep 30, 2023-$0.34N/AN/AN/AN/AN/AN/AN/ANov 9, 2023$257606
    Jun 30, 2023$0.29N/AN/AN/AN/AN/AN/A0 up, 0 downAug 14, 2023$762658
    Mar 31, 2023-$0.57-$0.80N/A+28.80%BeatN/AN/A0 up, 0 downMay 16, 2023$1.23M
    Dec 31, 2022-$3.27-$1.00-$1.00 - -$1.00-227.00%MissN/A10 up, 0 downMar 22, 2023$759143
    Sep 30, 2022-$0.80-$1.30-$1.40 - -$1.00+38.46%BeatN/A30 up, 0 downNov 10, 2022$999571
    Jun 30, 2022-$1.10-$1.03N/A-6.80%MissN/A30 up, 0 downAug 11, 2022$790508
    Mar 31, 2022-$1.20-$1.33-$1.40 - -$1.20+9.77%BeatN/A30 up, 0 downMay 13, 2022$964322
    Dec 31, 2021-$1.10-$1.27-$1.40 - -$1.20+13.39%BeatN/A40 up, 0 downMar 17, 2022$1.24M
    Sep 30, 2021-$1.50-$1.27-$1.30 - -$1.20-18.11%MissN/A4N/ANov 10, 2021N/A
    Jun 30, 2021-$1.30-$1.17-$1.50 - -$1.00-11.11%MissN/A4N/AAug 10, 2021N/A
    Mar 31, 2021-$1.60-$1.45-$1.70 - -$1.00-10.34%MissN/A4N/AMay 12, 2021N/A
    Dec 31, 2020-$1.80-$1.60-$1.70 - -$1.50-12.50%MissN/A2N/AMar 9, 2021$215
    Sep 30, 2020-$1.60-$1.45-$1.50 - -$1.40-10.34%MissN/A2N/ANov 9, 2020N/A
    Jun 30, 2020-$1.40-$1.43-$1.50 - -$1.40+2.10%BeatN/A4N/AAug 10, 2020$466785
    Mar 31, 2020-$1.40-$1.23-$1.40 - -$0.60-13.82%MissN/A5N/AMay 11, 2020N/A
    Dec 31, 2019-$1.10-$1.26-$1.40 - -$1.20+12.70%BeatN/A5N/AMar 12, 2020$213194
    Sep 30, 2019-$1.20-$1.32-$1.50 - -$1.20+9.09%BeatN/A5N/ANov 12, 2019N/A
    Jun 30, 2019-$1.20-$1.27-$1.30 - -$1.20+5.51%BeatN/A5N/AAug 8, 2019N/A
    Mar 31, 2019-$1.20-$1.30-$2.20 - -$1.20+7.69%BeatN/A4N/AMay 9, 2019N/A
    Dec 31, 2018-$10.20-$2.03-$2.80 - -$1.20-402.46%MissN/A3N/AMar 15, 2019$6
    Sep 30, 2018-$3.20-$4.40N/A+27.27%BeatN/AN/AN/ANov 13, 2018N/A
    Jun 30, 2018-$0.41N/AN/AN/AN/AN/AN/AN/AAug 9, 2018$205994
    Mar 31, 2018-$0.30-$0.30N/A0.00%In lineN/AN/AN/AMay 15, 2018N/A
    Dec 31, 2017-$3.00-$5.00N/A+40.00%BeatN/AN/AN/AMar 23, 2018N/A
    Sep 30, 2017-$0.39N/AN/AN/AN/AN/AN/AN/ANov 14, 2017$183064
    Jun 30, 2017-$0.22N/AN/AN/AN/A-163.3%N/AN/AAug 7, 2017N/A
    Mar 31, 2017-$0.29N/AN/AN/AN/AN/AN/AN/AMay 5, 2017N/A
    Dec 31, 2016-$0.19N/AN/AN/AN/AN/AN/AN/AMar 14, 2017N/A
    Sep 30, 2016-$0.29N/AN/AN/AN/A-178.4%N/AN/ANov 4, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.85, after -$1.20 the year before. It was -$0.93 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.85N/A
    Dec 31, 2024-$1.20N/A
    Dec 31, 2023-$1.10N/A
    Dec 31, 2022-$6.37N/A
    Dec 31, 2021-$5.50N/A
    Dec 31, 2020-$6.20N/A
    Dec 31, 2019-$4.70N/A
    Dec 31, 2018-$14.11N/A
    Dec 31, 2017-$3.90N/A
    Dec 31, 2016-$0.93N/A

    Frequently Asked Questions About MRKR

    When is Marker Therapeutics's next earnings date?

    Marker Therapeutics's next earnings report is expected for Mar 16, 2027.

    Did MRKR beat earnings estimates last quarter?

    Yes. Marker Therapeutics reported EPS of -$0.09 for the quarter ended Jun 30, 2026, above the -$0.25 estimate, a 64.00% surprise.

    What EPS do analysts expect from MRKR next quarter?

    The consensus EPS estimate for Marker Therapeutics for the quarter ending Dec 31, 2026 is -$0.22 from 5 analysts, with estimates from -$0.31 to -$0.13.

    How often does MRKR beat earnings estimates?

    Marker Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +22.00%.